{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:58:48Z","timestamp":1791331128913,"version":"4.3.1"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T00:00:00Z","timestamp":1687824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p\/>\n                  <jats:sec>\n                    <jats:title>OBJECTIVES<\/jats:title>\n                    <jats:p>Skip-N2 metastasis (N0N2), thus N2 metastasis in the absence of N1 metastasis, occurs in \u223c20\u201330% of non-small-cell lung cancer patients. N0N2 patients have a better prognosis than continuous-N2 metastasis (N1N2) patients following surgery. However, this effect remains controversial. Therefore, we conducted a multicentre study to compare the long-term survival and disease-free interval (DFI) of N1N2- and N0N2 patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>One- and 3-year survival rates were measured. Kaplan\u2013Meier curves and a Cox proportional hazards model assessed survival and were used to identify prognostic factors for overall survival. In addition, we performed propensity score matching (PSM) to rule out confounding factors. All patients received adjuvant chemoradiation therapy according to European guidelines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>Between January 2010 and December 2020, 218 stage IIIA\/B N2 patients were included in our analysis. The Cox regression analysis revealed that N1N2 significantly influenced the overall survival rate. Before PSM, N1N2 patients showed significantly more metastatic lymph nodes (P\u2009&amp;lt;\u20090.001) and significantly larger tumours (P\u2009=\u20090.05). After PSM, baseline characteristics did not differ between groups. Before and after PSM, N0N2 patients showed significantly better 1- (P\u2009=\u20090.01; P\u2009=\u20090.009) and 3-year (P\u2009&amp;lt;\u20090.001) survival rates than N1N2 patients. Furthermore, N0N2 patients showed significantly longer DFI than N1N2 patients before and after PSM (P\u2009&amp;lt;\u2009000.1).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>Prior and after PSM analysis, N0N2 patients were confirmed to have better survival and DFI than N1N2 patients. Our results demonstrate that stage IIIA\/B N2 patients are heterogeneous and would benefit from a more precise subdivision and differential treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ejcts\/ezad247","type":"journal-article","created":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T02:08:10Z","timestamp":1687831690000},"source":"Crossref","is-referenced-by-count":6,"title":["Do skip-N2 metastases significantly impact overall survival and disease-free interval in N2 non-small-cell lung cancer patients? A multicentre analysis"],"prefix":"10.1093","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7118-8432","authenticated-orcid":false,"given":"Georg","family":"Schlachtenberger","sequence":"first","affiliation":[{"name":"Department of Cardiothoracic Surgery, University Hospital of Cologne , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Schallenberg","sequence":"additional","affiliation":[{"name":"Department of Pathology, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0878-0406","authenticated-orcid":false,"given":"Fabian","family":"Doerr","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, University Medicine Essen\u2014Ruhrlandklinik, University Duisburg-Essen , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hruy","family":"Menghesha","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, University Medicine Essen\u2014Ruhrlandklinik, University Duisburg-Essen , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7232-3330","authenticated-orcid":false,"given":"Christopher","family":"Gaisendrees","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, University Hospital of Cologne , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Amorin","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, University Hospital of Cologne , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinna","family":"Grathwohl","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, University Hospital of Cologne , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard","family":"B\u00fcttner","sequence":"additional","affiliation":[{"name":"Department of Pathology, University Hospital of Cologne , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3537-6011","authenticated-orcid":false,"given":"Alexander","family":"Quaas","sequence":"additional","affiliation":[{"name":"Department of Pathology, University Hospital of Cologne , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Horst","sequence":"additional","affiliation":[{"name":"Department of Pathology, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick","family":"Klauschen","sequence":"additional","affiliation":[{"name":"Department of Pathology, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaj","family":"Frost","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Respiratory Medicine, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens-C","family":"Rueckert","sequence":"additional","affiliation":[{"name":"Department of Surgery, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Neudecker","sequence":"additional","affiliation":[{"name":"Department of Surgery, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"H\u00f6pker","sequence":"additional","affiliation":[{"name":"University of Cologne, Faculty of Medicine, University Hospital Cologne, Clinic III for Internal Medicine , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8437-4119","authenticated-orcid":false,"given":"Thorsten","family":"Wahlers","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, University Hospital of Cologne , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6479-8774","authenticated-orcid":false,"given":"Khosro","family":"Hekmat","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, University Hospital of Cologne , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias B","family":"Heldwein","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, University Hospital of Cologne , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,6,27]]},"reference":[{"key":"2023070505165381100_ezad247-B1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"2023070505165381100_ezad247-B2","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/annonc\/mdx222","article-title":"Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"28","author":"Postmus","year":"2017","journal-title":"Ann Oncol"},{"key":"2023070505165381100_ezad247-B3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/JTO.0b013e3181c5920c","article-title":"Trends in stage distribution for patients with non-small cell lung cancer: a National Cancer Database survey","volume":"5","author":"Morgensztern","year":"2010","journal-title":"J Thorac Oncol"},{"key":"2023070505165381100_ezad247-B4","doi-asserted-by":"crossref","first-page":"749156","DOI":"10.3389\/fsurg.2021.749156","article-title":"The impact of skip vs. non-skip N2 lymph node metastasis on the prognosis of non-small-cell lung cancer: a systematic review and meta-analysis","volume":"8","author":"Wang","year":"2021","journal-title":"Front Surg"},{"key":"2023070505165381100_ezad247-B5","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.athoracsur.2018.07.033","article-title":"Multimodality therapy for N2 non-small cell lung cancer: an evolving paradigm","volume":"107","author":"Spicer","year":"2019","journal-title":"Ann Thorac Surg"},{"key":"2023070505165381100_ezad247-B6","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/ejcts\/ezab372","article-title":"Significantly favourable outcome for patients with non-small-cell lung cancer stage IIIA\/IIIB and single-station persistent N2 (skip or additionally N1) disease after multimodality treatment","volume":"61","author":"Stamatis","year":"2022","journal-title":"Eur J Cardiothorac Surg"},{"key":"2023070505165381100_ezad247-B7","doi-asserted-by":"crossref","first-page":"304","DOI":"10.5761\/atcs.oa.20-00289","article-title":"The significance of skip mediastinal lymph node metastasis in the prognosis of patients with resected non-small-cell lung carcinoma: is it really a better N2 disease subtype?","volume":"27","author":"Seyrek","year":"2021","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"2023070505165381100_ezad247-B8","doi-asserted-by":"crossref","first-page":"101505","DOI":"10.1016\/j.suronc.2020.11.019","article-title":"Postoperative long-term survival of non-small cell lung cancer patients with skip-N2 metastases","volume":"38","author":"Schlachtenberger","year":"2021","journal-title":"Surg Oncol"},{"key":"2023070505165381100_ezad247-B9","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1097\/JTO.0000000000000678","article-title":"The International Association for the Study of Lung Cancer Lung Cancer Staging Project: proposals for the revision of the N descriptors in the forthcoming 8th edition of the TNM Classification for Lung Cancer","volume":"10","author":"Asamura","year":"2015","journal-title":"J Thorac Oncol"},{"key":"2023070505165381100_ezad247-B10","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jtho.2015.09.009","article-title":"The IASLC Lung Cancer Staging Project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM Classification for Lung Cancer","volume":"11","author":"Goldstraw","year":"2016","journal-title":"J Thorac Oncol"},{"key":"2023070505165381100_ezad247-B11","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/ca.20790","article-title":"The problem of direct lymph drainage of the bronchopulmonary segments into the mediastinal and hilar lymph nodes","volume":"22","author":"Topol","year":"2009","journal-title":"Clin Anat"},{"key":"2023070505165381100_ezad247-B12","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.athoracsur.2004.06.081","article-title":"Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis","volume":"79","author":"Riquet","year":"2005","journal-title":"Ann Thorac Surg"},{"key":"2023070505165381100_ezad247-B13","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1001\/jamaoncol.2021.4932","article-title":"Update of incidence, prevalence, survival, and initial treatment in patients with non-small cell lung cancer in the US","volume":"7","author":"Ganti","year":"2021","journal-title":"JAMA Oncol"},{"key":"2023070505165381100_ezad247-B14","doi-asserted-by":"crossref","first-page":"e346","DOI":"10.1016\/j.cllc.2018.12.007","article-title":"Role of skip mediastinal lymph node metastasis for patients with resectable non-small-cell lung cancer: a propensity score matching analysis","volume":"20","author":"Wang","year":"2019","journal-title":"Clin Lung Cancer"},{"key":"2023070505165381100_ezad247-B15","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1016\/j.ejso.2019.12.015","article-title":"Survival benefit of skip metastases in surgically resected N2 non-small cell lung cancer: a multicenter observational study of a large cohort of the Chinese patients","volume":"46","author":"Li","year":"2020","journal-title":"Eur J Surg Oncol"},{"key":"2023070505165381100_ezad247-B16","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/icvts\/ivy244","article-title":"Single-station skip-N2 disease: good prognosis in resected non-small-cell lung cancer (long-term results in skip-N2 disease)","volume":"28","author":"Yazgan","year":"2019","journal-title":"Interact CardioVasc Thorac Surg"},{"key":"2023070505165381100_ezad247-B17","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.3390\/cancers13061326","article-title":"Survival analysis in single N2 station lung adenocarcinoma: the prognostic role of involved lymph nodes and adjuvant therapy","volume":"13","author":"Chiappetta","year":"2021","journal-title":"Cancers"},{"key":"2023070505165381100_ezad247-B18","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/s41598-017-00619-5","article-title":"Prognostic and predictive effects of positive lymph node number or ratio in NSCLC","volume":"7","author":"Ding","year":"2017","journal-title":"Sci Rep"},{"key":"2023070505165381100_ezad247-B19","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/jjco\/hyz120","article-title":"Prognostic value of lymph node ratio in non-small-cell lung cancer: a meta-analysis","volume":"50","author":"Zhou","year":"2020","journal-title":"Jpn J Clin Oncol"},{"key":"2023070505165381100_ezad247-B20","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.athoracsur.2013.11.051","article-title":"Metastasis to subsegmental and segmental lymph nodes in patients resected for non-small cell lung cancer: prognostic impact","volume":"97","author":"Rena","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"2023070505165381100_ezad247-B21","doi-asserted-by":"crossref","first-page":"e423","DOI":"10.1016\/j.cllc.2020.02.027","article-title":"Skip N2 metastasis in pulmonary adenocarcinoma: good prognosis similar to N1 disease","volume":"21","author":"Wang","year":"2020","journal-title":"Clin Lung Cancer"},{"key":"2023070505165381100_ezad247-B22","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMoa2027071","article-title":"Osimertinib in resected EGFR-mutated non-small-cell lung cancer","volume":"383","author":"Wu","year":"2020","journal-title":"N Engl J Med"},{"key":"2023070505165381100_ezad247-B23","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/S0140-6736(21)02098-5","article-title":"Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial","volume":"398","author":"Felip","year":"2021","journal-title":"Lancet"},{"key":"2023070505165381100_ezad247-B24","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.jtho.2020.12.015","article-title":"Four-year survival with durvalumab after chemoradiotherapy in stage III NSCLC\u2014an update from the PACIFIC trial","volume":"16","author":"Faivre-Finn","year":"2021","journal-title":"J Thorac Oncol"},{"key":"2023070505165381100_ezad247-B25","first-page":"1","year":"2022"},{"key":"2023070505165381100_ezad247-B26","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S1470-2045(21)00606-9","article-title":"Postoperative radiotherapy versus no postoperative radiotherapy in patients with completely resected non-small-cell lung cancer and proven mediastinal N2 involvement (Lung ART): an open-label, randomised, phase 3 trial","volume":"23","author":"Le Pechoux","year":"2022","journal-title":"Lancet Oncol"},{"key":"2023070505165381100_ezad247-B27","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1056\/NEJMoa2202170","article-title":"Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer","volume":"386","author":"Forde","year":"2022","journal-title":"N Engl J Med"},{"key":"2023070505165381100_ezad247-B28","doi-asserted-by":"crossref","first-page":"4806","DOI":"10.21037\/jtd.2018.07.125","article-title":"Long term and disease-free survival following surgical resection of occult N2 lung cancer","volume":"10","author":"Kirmani","year":"2018","journal-title":"J Thorac Dis"}],"container-title":["European Journal of Cardio-Thoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejcts\/advance-article-pdf\/doi\/10.1093\/ejcts\/ezad247\/50725329\/ezad247.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejcts\/article-pdf\/64\/1\/ezad247\/50801041\/ezad247.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejcts\/article-pdf\/64\/1\/ezad247\/50801041\/ezad247.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T09:31:13Z","timestamp":1688549473000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejcts\/article\/doi\/10.1093\/ejcts\/ezad247\/7208867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,27]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,7,3]]}},"URL":"https:\/\/doi.org\/10.1093\/ejcts\/ezad247","relation":{},"ISSN":["1873-734X"],"issn-type":[{"value":"1873-734X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,7,1]]},"published":{"date-parts":[[2023,6,27]]},"article-number":"ezad247"}}